Genomic Analysis of the New Ebola Bundibugyo Virus Strain That Emerged in DRC Reveals 23 Unique Mutations
Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 07, 2026 1 hour, 34 minutes ago
Medical News: A detailed genomic investigation into the ongoing Bundibugyo virus disease (BVD) outbreak affecting the Democratic Republic of Congo (DRC) and neighboring Uganda has uncovered a surprisingly diverse and evolving strain of the Ebola Bundibugyo virus. Scientists studying the outbreak have identified 23 unique mutations across just 10 available viral genomes, raising important questions about how long the virus has been circulating undetected and whether some of the newly acquired genetic changes could eventually influence transmission, immune evasion, or disease severity.
Scientists uncover 23 mutations in a newly evolving Bundibugyo Ebola virus strain, suggesting weeks of undetected
transmission before the outbreak was recognized
While researchers caution that there is currently no evidence that the virus has become significantly more dangerous than previously known Bundibugyo virus strains, the findings reveal that the outbreak is much more genetically complex than initially expected. The data suggest that viral transmission was likely occurring silently for weeks before the outbreak came to the attention of health authorities.
The genomic analysis was conducted using outbreak-associated Bundibugyo virus sequences collected from cases in the DRC and Uganda and shared through the Pathoplexus genomic surveillance platform. The work involved researchers and collaborating laboratories participating in international Ebola surveillance efforts and the Virological scientific community. Scientists utilized advanced phylogenetic and molecular evolutionary techniques to reconstruct the outbreak's origins, identify emerging mutations, and estimate transmission dynamics.
A Rare and Often Overlooked Ebola Virus
Bundibugyo ebolavirus is one of the six known Ebola virus species and is considerably less studied than the more infamous Zaire ebolavirus, which was responsible for the devastating West African Ebola epidemic between 2013 and 2016.
First identified in Uganda in 2007, Bundibugyo virus causes a severe hemorrhagic fever characterized by high fever, fatigue, muscle pain, vomiting, diarrhea, internal bleeding, organ damage, and in severe cases, death. Although previous Bundibugyo outbreaks have generally shown somewhat lower fatality rates than outbreaks caused by Zaire ebolavirus, the virus remains a major public health threat due to its ability to spread through direct contact with infected bodily fluids and contaminated materials.
One of the greatest challenges in responding to Bundibugyo virus outbreaks is the relative lack of genomic data compared to other Ebola species. As a result, every new outbreak provides a critical opportunity to better understand how this virus evolves and adapts.
Scientists Trace the Outbreak Back to Early March
One of the most important findings from the new analysis concerns the likely timing of the outbreak's emergence.
Using molecular clock techniques and multiple evolutionary models, researchers estimated that all currently sampled viruses descended from a common ancestor that existed between March 1 and March 15, 2026.
This means the virus was likely spreading among humans weeks before the first available genetic samples were collected in May.
The finding is particularly important because it suggests that health authorities may have detected the outbreak only after substantial community transmission had already occurred. The genetic diversity observed among the sampled viruses strongly supports this conclusion.
According to the researchers, the available sequences do not appear to represent the earliest stages of transmission. Instead, they reflect an outbreak that had already become established and diversified within multiple transmission chains.
Twenty-Three Mutations Reveal an Actively Evolving Virus
The most striking discovery was the identification of 23 unique mutations across the ten available outbreak genomes.
Mutations occur naturally whenever viruses replicate. Most mutations are biologically neutral and have little or no effect on viral behavior. However, some mutations can alter viral proteins and potentially influence how efficiently a virus replicates, infects cells, spreads between hosts, or interacts with the immune system.
Of the 23 identified mutations, 11 occurred within protein-coding regions of the viral genome.
These coding mutations were found within several important viral genes, including:
-Nucleoprotein (NP)
-Glycoprotein (GP)
-Soluble glycoprotein (sGP)
-Small secreted glycoprotein (ssGP)
-RNA polymerase (L protein)
Researchers noted that the earliest sampled virus differed from the reconstructed ancestral outbreak strain by only two mutations, whereas other sampled viruses contained between three and five mutations.
This pattern indicates that significant genetic diversification had already occurred before the first viral genomes became available for analysis.
Mutations in the Glycoprotein Region Draw Special Attention
Among all the observed changes, scientists are paying particularly close attention to five mutations located within the glycoprotein gene.
The glycoprotein is one of the most important proteins encoded by Ebola viruses. It forms the spikes that protrude from the virus surface and is directly responsible for attaching to and entering human cells.
The five glycoprotein-associated mutations identified were:
-T6657C
-C7049T
-T7405C
-T7447C
-T7975C
Four of these five mutations resulted in amino acid changes, meaning they altered the structure of the proteins produced by the virus.
Such mutations are known as non-synonymous mutations and are often closely monitored because they have the potential to influence viral biology.
Although the precise effects of these mutations remain unknown, scientists note that glycoprotein mutations in Ebola viruses can theoretically affect several important properties:
-Cell Entry Efficiency
Changes in glycoprotein structure may influence how effectively the virus binds to host-cell receptors. Enhanced binding efficiency could potentially increase infectivity, although no evidence currently suggests this is occurring in the present outbreak.
-Tissue Tropism
Certain glycoprotein mutations may alter which tissues or cell types the virus can infect most efficiently. This could theoretically influence disease manifestations and severity.
-Immune Recognition
The glycoprotein is one of the primary targets of antibodies produced by the immune system. Structural changes may affect how effectively antibodies recognize and neutralize the virus.
-Viral Stability
Some mutations can alter protein folding and stability, potentially affecting how well viral particles survive under different environmental conditions.
Researchers emphasize that these possibilities remain theoretical at present and require laboratory validation before any conclusions can be reached.
Changes Found in Other Critical Viral Proteins
In addition to glycoprotein mutations, the study identified mutations affecting several other biologically important regions.
Mutations within the nucleoprotein gene are noteworthy because this protein helps package and protect the viral RNA genome. Alterations in nucleoprotein function can potentially influence replication efficiency and viral assembly.
Scientists also observed mutations affecting the L gene, which encodes the virus's RNA-dependent RNA polymerase. This enzyme is essentially the virus's replication machinery and is responsible for copying the viral genome during infection.
Historically, mutations affecting viral polymerases have occasionally been associated with altered replication kinetics in various RNA viruses. However, the functional significance of the newly identified Bundibugyo virus polymerase mutations remains unknown.
Importantly, researchers found no evidence of dramatic genetic shifts that would immediately suggest the emergence of a radically different or more virulent strain.
Transmission Dynamics Suggest Continued Spread
The investigators also used the genetic data to estimate the outbreak's growth rate.
Their models indicate that the epidemic's doubling time may range from approximately 15.2 to 24.5 days.
While this represents a slower growth rate than some historic Ebola outbreaks, the estimates still indicate sustained transmission.
The calculated basic reproduction number (R0) ranged from approximately 1.31 to 1.55.
An R0 greater than 1 means each infected individual is, on average, transmitting the virus to more than one additional person, allowing the outbreak to continue expanding.
However, researchers caution that these estimates remain highly uncertain because they are based on only ten viral genomes collected over a relatively short time period.
Evidence of Hidden Transmission Chains
Perhaps the most concerning aspect of the analysis is what it reveals about hidden transmission.
The genetic diversity observed among the sampled viruses appears too extensive to represent a newly emerging outbreak.
Instead, the mutation patterns strongly suggest that multiple transmission chains were already active before genomic surveillance began.
This means that some infected individuals may never have been identified, tested, or included in official outbreak statistics.
Independent epidemiological investigations and situation reports have similarly suggested that the outbreak was likely substantially larger than indicated by available sequencing data alone.
Why Continued Genomic Surveillance Matters
The discovery of 23 unique mutations in such a limited number of genomes highlights the importance of continued sequencing efforts.
Every newly sequenced virus provides scientists with additional information about how the outbreak is evolving and whether potentially important mutations are becoming more common.
This
Medical News report underscores the growing role of genomic surveillance in modern outbreak response. Real-time genetic monitoring allows researchers to detect emerging evolutionary patterns, identify transmission pathways, and evaluate whether viruses are acquiring mutations that could influence public health risks.
As additional viral genomes become available from the DRC and Uganda, scientists will be able to determine whether the currently observed mutations are isolated events or the beginning of broader evolutionary trends.
Conclusion
The current Bundibugyo Ebola outbreak in the DRC and Uganda appears to involve a genetically diverse viral population that likely began circulating weeks before detection. The identification of 23 unique mutations, including several non-synonymous changes within the crucial glycoprotein region, highlights an actively evolving virus that warrants close scientific scrutiny. While there is presently no evidence that these mutations have increased transmissibility, virulence, or immune escape capabilities, their location within key viral proteins makes continued genomic surveillance essential for understanding the future trajectory of this outbreak and any potential biological changes that may emerge.
The genomic analysis of the new Bundibugyos strain can be found at virological.org
https://virological.org/t/molecular-evolutionary-analysis-of-the-current-bundibugyo-virus-disease-outbreak-in-drc-and-uganda/1042
For the latest Ebola news, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/new-ebola-outbreak-infects-246-and-kills-65-in-drc-with-new-virus-strain-possibly-involved
https://www.thailandmedical.news/news/preliminary-findings-indicate-that-a-new-sublineage-of-the-bundyibugyo-strain-is-behind-the-ebola-virus-outbreak-in-drc
https://www.thailandmedical.news/news/initial-genomic-sequencing-data-shows-that-bundibugyo-ebola-outbreak-in-drc-is-a-genetically-distinct-new-spillover
https://www.thailandmedical.news/news/is-the-new-ebola-bundibugyo-strain-from-a-spillover-event-adapted-for-better-cell-entry-and-airborne-transmission
https://www.thailandmedical.news/articles/ebola
Share
Tweet
Share
